Societe Generale Effekten (S27667) Cotización

There's more reason for the short to pound this down though.

Or Armen 😆 

I don't have an opinion, just hope like hell we get something and soon.

Yes he should issue a 8-K and a PR but he isn't going to as I have been debating it with him for an hour. Once the LOI is completed he will then issue the announcement He is stubborn that way. Only announces something when it's completed 

I'm not seeing any NEW buying (as of today) from any these NEW posts that are being repeated over and over... it most be copy, paste and get paid by the post!! 🙄🤣

HCWB: Hopefully, as this one is by no means totally 'over'.

yup

1B shares authorized

AI tells us

55.28 million
After the reverse split, Nikola Motors has 55.28 million shares outstanding1. The number of authorized shares will be reduced from 1.6 billion to 1 billion2. As of October 28, 2024, the company h

Dude, opportunity cost does not bother him. Some say he has been gas lighting here for close to a decade. The concept of return on investment does not exist for these folks! I wonder why? ;)

VKTX

Anyone have an explanation for the low dose result in this chart?

https://x.com/RNAiAnalyst/status/1858954931291770990

The inspection isn't completed yet, and there could be an RFI afterwards. Therefore, you may need to factor in an additional 60-day delay once the inspection is finished. Given the intensity of the inspection, I doubt that an RFI could be avoided. Let's assume the inspection is completed by December

President-elect Donald Trump announced Tuesday that he has chosen Mehmet Oz, also known as Dr. Oz, to helm the Centers for Medicare and Medicaid Services (CMS).

Trump announced his decision to move forward with Oz in a post to Truth Social. Oz is a prominent figure in part because of

Were going to, or are about too.

🧐🤔

$RIME nice eps and news can come as early as tomorrow

STI...63...Looking for .70 Break tomorrow...🥳if not then I am out...

NEAR TEERM NEWS ON THE HORIZON

Alzheimer’s disease: Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an
upcoming peer-reviewed journal

Alzheimer’s disease: Full regulatory submission of blarcamesine in Europe (EMA)

The production values of this sh_t show are stellar. Stellarly awful.

My guess is it would pay $750 per share of preferreds towards escrow holders !! 2 shares x $750 = $1500.00 !! Is my understanding! What is your opinion??

LMAO that never happened

Those LOI were from the merger with Durham Black. They were all canceled whether merger was unwound. The LOI in the Q3 is a new one that is strictly for Digibriks it's self. Two separate incidents 

STI...63...Looking for .70 Break tomorrow...🥳if not then I am out...

https://www.otcmarkets.com/filing/html?id=17987177&guid=4uY-ke82wLvrh3h
10-Q Filed 11/19/2024 for 30 SEP 2024.
Cheers!

STI...63...Looking for .70 Break tomorrow...🥳if not then I am out...

The Federal Vacancies Reform Act of 1998 establishes requirements for temporarily filling vacant positions in Executive Branch

The Federal Vacancies Reform Act of 1998 establishes requirements for temporarily filling vacant positions in Executive Branch agencies that require president

Glad I picked $4,500 of shares @ 44¢.

1 B after the split (reverse)

wow - I think I might remember 200MM

Will go to investors news and look